Showing 1 - 10 of 22
Quantifying national spending on wellness and prevention / George Miller, Charles Roehrig, Paul Hughes-Cromwick, Craig Lake -- Spillover effects of prescription drug withdrawals / John Cawley, John A. Rizzo -- The psychology of nutrition messages / Heather Schofield, Sendhil Mullainathan --...
Persistent link: https://www.econbiz.de/10012049663
Persistent link: https://www.econbiz.de/10003894044
Persistent link: https://www.econbiz.de/10003411356
Persistent link: https://www.econbiz.de/10003972551
Persistent link: https://www.econbiz.de/10010339707
Persistent link: https://www.econbiz.de/10009535811
Prescription opioid use among women of reproductive age and pregnant women is relatively common and growing prescription opioid use is associated with a commensurate increase in opioid use disorder (OUD) among pregnant women and neonatal abstinence syndrome (NAS) among infants. In this article,...
Persistent link: https://www.econbiz.de/10012841425
We examine whether obtaining prescription drug insurance through the Medicare Part D program affected hospital admissions, expenditures associated with those admissions, and mortality. We use a large, geographically diverse sample of Medicare beneficiaries and exploit the natural experiment of...
Persistent link: https://www.econbiz.de/10013057818
This article presents estimates of the effects of state prescription opioid policies on prescription opioid sales, mortality and socioeconomic outcomes of adults. Results indicate that state implementation of a “modern” PDMP is associated with decreases in opioid sales of between 5% and 20%...
Persistent link: https://www.econbiz.de/10013313249
Prescription opioid use among women of reproductive age and pregnant women is relatively common and growing prescription opioid use is associated with a commensurate increase in opioid use disorder (OUD) among pregnant women and neonatal abstinence syndrome (NAS) among infants. In this article,...
Persistent link: https://www.econbiz.de/10012479273